Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C Pearson

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Jac-Antimicrobial Resistance|January 1, 2024
Evaluating the incidence of acute kidney injury and gentamicin synergy dosing for endocarditisSkyler Starkel, Melanie Goodberlet, Brian Schuler, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental StudyYazed Saleh Alsowaida, David W Kubiak, Brandon Dionne, et al.
Open Forum Infectious Diseases|April 1, 2024
Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for CliniciansChristo Cimino, Christina G Rivera, Jeffrey C Pearson, et al.
Open Forum Infectious Diseases|October 21, 2022
Evaluation of Vancomycin Accumulation in Patients With ObesityMaha S Assadoon, Jeffrey C Pearson, David W Kubiak, et al.
Open Forum Infectious Diseases|October 2, 2025
Evaluating the Efficacy of Crushed Bictegravir/Emtricitabine/Tenofovir Alafenamide Administered via TubeJoshua Mercure, Kayla Bey, Eric Gillett, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 28, 2023
Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) programRachel S Britt, Jeffrey C Pearson, Mary T LaSalvia, et al.
Open Forum Infectious Diseases|March 25, 2024
Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective AnalysisNick Petrucelli, Bryan D Hayes, Nidhi Shelat, et al.
Cell Reports. Medicine|April 27, 2022
Treating COVID-19: Evolving approaches to evidence in a pandemicCheryl K Lee, Louis T Merriam, Jeffrey C Pearson, et al.
Journal of Clinical Pharmacology|May 29, 2026
Evaluation of Vancomycin Dosing Practices in Critically Ill Patients Receiving Accelerated Venovenous HemofiltrationNihad Medar, Lydia R Ware, Jeremy R DeGrado, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2025
Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosisDominic M H Tong, Maria-Stephanie A Hughes, Jasmine Hu, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Jac-Antimicrobial Resistance|January 1, 2024
Evaluating the incidence of acute kidney injury and gentamicin synergy dosing for endocarditisSkyler Starkel, Melanie Goodberlet, Brian Schuler, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental StudyYazed Saleh Alsowaida, David W Kubiak, Brandon Dionne, et al.
Open Forum Infectious Diseases|April 1, 2024
Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for CliniciansChristo Cimino, Christina G Rivera, Jeffrey C Pearson, et al.
Open Forum Infectious Diseases|October 21, 2022
Evaluation of Vancomycin Accumulation in Patients With ObesityMaha S Assadoon, Jeffrey C Pearson, David W Kubiak, et al.
Open Forum Infectious Diseases|October 2, 2025
Evaluating the Efficacy of Crushed Bictegravir/Emtricitabine/Tenofovir Alafenamide Administered via TubeJoshua Mercure, Kayla Bey, Eric Gillett, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 28, 2023
Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) programRachel S Britt, Jeffrey C Pearson, Mary T LaSalvia, et al.
Open Forum Infectious Diseases|March 25, 2024
Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective AnalysisNick Petrucelli, Bryan D Hayes, Nidhi Shelat, et al.
Cell Reports. Medicine|April 27, 2022
Treating COVID-19: Evolving approaches to evidence in a pandemicCheryl K Lee, Louis T Merriam, Jeffrey C Pearson, et al.
Journal of Clinical Pharmacology|May 29, 2026
Evaluation of Vancomycin Dosing Practices in Critically Ill Patients Receiving Accelerated Venovenous HemofiltrationNihad Medar, Lydia R Ware, Jeremy R DeGrado, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2025
Comparing two-sample log-linear exposure estimation with Bayesian model-informed precision dosing of tobramycin in adult patients with cystic fibrosisDominic M H Tong, Maria-Stephanie A Hughes, Jasmine Hu, et al.
Pageof 3